Virginia Commonwealth University

New compound discovered that rapidly kills liver cancer

Scientists have identified a new compound that rapidly kills hepatocellular carcinoma (HCC) cells, the most common form of liver cancer and fifth most common cancer worldwide, while sparing healthy tissue. The compound, Factor ...

Mar 14, 2012
popularity 5 / 5 (20) | comments 0 | with audio podcast

Research breakthrough could halt melanoma metastasis

In laboratory experiments, scientists have eliminated metastasis, the spread of cancer from the original tumor to other parts of the body, in melanoma by inhibiting a protein known as melanoma differentiation associated gene-9 ...

Nov 14, 2012
popularity 4.8 / 5 (6) | comments 0 | with audio podcast

Researchers overcome barrier to cancer immunotherapy

(Medical Xpress) -- In lab studies, researchers at Virginia Commonwealth University Massey Cancer Center have effectively reprogrammed cells of the innate and adaptive immune system to overcome a key cancer defense mechanism ...

Sep 02, 2011
popularity 5 / 5 (3) | comments 0 | with audio podcast

Scientists see potential in novel leukemia treatment

Scientists at Virginia Commonwealth University Massey Cancer Center may be one step closer to developing a new therapy for acute myeloid leukemia (AML) after discovering that the targeted agents obatoclax and sorafenib kill ...

May 22, 2012
popularity 5 / 5 (3) | comments 0

Cognitive behavioral therapy for better sleep

As the sun sets and day turns to night, we find ourselves growing weary, worn out from a busy day. We follow a ritual that leads us down the path to a restful slumber. We power down with perhaps a warm bath, brush our teeth, ...

Feb 25, 2014
popularity 5 / 5 (3) | comments 0

Researchers uncover allergy-cancer connection

While many are stocking up on allergy medicine in preparation for spring, a new study from researchers at Virginia Commonwealth University Massey Cancer Center has uncovered a new connection between allergy ...

Mar 19, 2014
popularity 5 / 5 (3) | comments 0